Gene · 4600
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Clathrin and Dynamin in Clathrin Mediated Endocytosis/Synaptic Vesicle Recycling and Implications in Neurological Diseases. | Front Cell Neurosci | 2021 | 35115907 | PubTator, text mining | PubMed |
| The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19. | Front Immunol | 2021 | 35095917 | PubTator, text mining | PubMed |
| Monolaurin Confers a Protective Effect Against Porcine Epidemic Diarrhea Virus Infection in Piglets by Regulating the Interferon Pathway. | Front Immunol | 2021 | 35095875 | PubTator, text mining | PubMed |
| Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration. | Front Immunol | 2021 | 35095855 | PubTator, text mining | PubMed |
| Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease Progression. | Front Immunol | 2021 | 35095832 | PubTator, text mining | PubMed |
| Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles. | Front Pharmacol | 2021 | 35095529 | PubTator, text mining | PubMed |
| Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation. | Front Immunol | 2021 | 35069519 | PubTator, text mining | PubMed |
| Differential Transcriptomic Response of Rainbow Trout to Infection with Two Strains of IPNV. | Viruses | 2021 | 35062225 | PubTator, text mining | PubMed |
| Extracellular Vesicles as a New Promising Therapy in HIV Infection. | Front Immunol | 2021 | 35058938 | PubTator, text mining | PubMed |
| Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA. | J Oncol | 2021 | 35003257 | PubTator, text mining | PubMed |
| COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets. | Front Genet | 2021 | 35003208 | PubTator, text mining | PubMed |
| Toward Overcoming Treatment Failure in Rheumatoid Arthritis. | Front Immunol | 2021 | 35003068 | PubTator, text mining | PubMed |
| Enterovirus A71 2B Inhibits Interferon-Activated JAK/STAT Signaling by Inducing Caspase-3-Dependent Karyopherin-α1 Degradation. | Front Microbiol | 2021 | 34992585 | PubTator, text mining | PubMed |
| Potential Molecular Mechanisms and Remdesivir Treatment for Acute Respiratory Syndrome Corona Virus 2 Infection/COVID 19 Through RNA Sequencing and Bioinformatics Analysis. | Bioinform Biol Insights | 2021 | 34992355 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Rat Lungs Exposed to Moxa Smoke after Acute Toxicity Testing. | Evid Based Complement Alternat Med | 2021 | 34961819 | PubTator, text mining | PubMed |
| Update on the Inactivation Procedures for the Vaccine Development Prospects of a New Highly Virulent RGNNV Isolate. | Vaccines (Basel) | 2021 | 34960187 | PubTator, text mining | PubMed |
| Manipulable Electronic and Optical Properties of Two-Dimensional MoSTe/MoGe2N4 van der Waals Heterostructures. | Nanomaterials (Basel) | 2021 | 34947685 | PubTator, text mining | PubMed |
| Research progress in hepatitis B virus covalently closed circular DNA. | Cancer Biol Med | 2021 | 34931766 | PubTator, text mining | PubMed |
| SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. | Signal Transduct Target Ther | 2021 | 34921131 | PubTator, text mining | PubMed |
| Review of strategies toward the development of alloy two-dimensional (2D) transition metal dichalcogenides. | iScience | 2021 | 34917904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4600/papers?page=39